BellaEng
2021-12-20
Great
Novavax expected to start delivering COVID-19 shots to EU in first quarter 2022 -EU source
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":693819708,"tweetId":"693819708","gmtCreate":1639998984865,"gmtModify":1639998985386,"author":{"id":3576533774112300,"idStr":"3576533774112300","authorId":3576533774112300,"authorIdStr":"3576533774112300","name":"BellaEng","avatar":"https://static.tigerbbs.com/dde1682b37a7cdb8f3de06cedadd8083","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":56,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Great</p></body></html>","htmlText":"<html><head></head><body><p>Great</p></body></html>","text":"Great","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/693819708","repostId":1102066717,"repostType":4,"repost":{"id":"1102066717","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639998810,"share":"https://www.laohu8.com/m/news/1102066717?lang=&edition=full","pubTime":"2021-12-20 19:13","market":"us","language":"en","title":"Novavax expected to start delivering COVID-19 shots to EU in first quarter 2022 -EU source","url":"https://stock-news.laohu8.com/highlight/detail?id=1102066717","media":"Reuters","summary":"BRUSSELS, Dec 20 (Reuters) - Novavax(NVAX.O)is expected to start delivering its COVID-19 vaccines to","content":"<p>BRUSSELS, Dec 20 (Reuters) - Novavax(NVAX.O)is expected to start delivering its COVID-19 vaccines to the European Union in the first quarter of 2022, an EU source said, as experts for the region's drug regulator met on Monday to decide whether to approve the shot.</p>\n<p>The EU Commission had no immediate comment and the U.S. biotech company was not immediately available for comment. The EU source declined to be identified because they were not authorised to speak to the media.</p>\n<p>If approved, the two-dose vaccine, branded Nuvaxovid, would be the fifth coronavirus shot to be brought on to the EU market and arrives as the Omicron coronavirus variant spreads.</p>\n<p>Earlier in the year, Novavax had told the European Union it planned to begin making first small shipments of its vaccine for the bloc towards the end of this year, with the bulk of supplies in 2022, an EU official told Reuters in May.</p>\n<p>The EU Commission and the company signed a contract in August for the delivery of up to 200 million doses, of which half is optional.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax expected to start delivering COVID-19 shots to EU in first quarter 2022 -EU source</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax expected to start delivering COVID-19 shots to EU in first quarter 2022 -EU source\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-20 19:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BRUSSELS, Dec 20 (Reuters) - Novavax(NVAX.O)is expected to start delivering its COVID-19 vaccines to the European Union in the first quarter of 2022, an EU source said, as experts for the region's drug regulator met on Monday to decide whether to approve the shot.</p>\n<p>The EU Commission had no immediate comment and the U.S. biotech company was not immediately available for comment. The EU source declined to be identified because they were not authorised to speak to the media.</p>\n<p>If approved, the two-dose vaccine, branded Nuvaxovid, would be the fifth coronavirus shot to be brought on to the EU market and arrives as the Omicron coronavirus variant spreads.</p>\n<p>Earlier in the year, Novavax had told the European Union it planned to begin making first small shipments of its vaccine for the bloc towards the end of this year, with the bulk of supplies in 2022, an EU official told Reuters in May.</p>\n<p>The EU Commission and the company signed a contract in August for the delivery of up to 200 million doses, of which half is optional.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102066717","content_text":"BRUSSELS, Dec 20 (Reuters) - Novavax(NVAX.O)is expected to start delivering its COVID-19 vaccines to the European Union in the first quarter of 2022, an EU source said, as experts for the region's drug regulator met on Monday to decide whether to approve the shot.\nThe EU Commission had no immediate comment and the U.S. biotech company was not immediately available for comment. The EU source declined to be identified because they were not authorised to speak to the media.\nIf approved, the two-dose vaccine, branded Nuvaxovid, would be the fifth coronavirus shot to be brought on to the EU market and arrives as the Omicron coronavirus variant spreads.\nEarlier in the year, Novavax had told the European Union it planned to begin making first small shipments of its vaccine for the bloc towards the end of this year, with the bulk of supplies in 2022, an EU official told Reuters in May.\nThe EU Commission and the company signed a contract in August for the delivery of up to 200 million doses, of which half is optional.","news_type":1},"isVote":1,"tweetType":1,"viewCount":376,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/693819708"}
精彩评论